Alnylam Regeneron collaboration to discover develop and commercialize RNAi therapeutics

Alnylam, Regeneron collaboration to discover, develop and commercialize RNAi therapeutics

07:32 EDT 9 Apr 2019 | Pharmaceutical Business Review

The collaboration will leverage both companies’ scientific and technological expertise and will build on Alnylam’s recent preclinical data showing potent and highly durable delivery of RNAi therapeutics to

More From BioPortfolio on "Alnylam, Regeneron collaboration to discover, develop and commercialize RNAi therapeutics"